Molecular Pharmacology
- Bachelor projects Molecular Pharmacology
- Master projects Molecular Pharmacology
- Pharmacology of Chronic Diseases and Aging
- MG: Endocrine system, Respiratory tract and Digestive Tract
- MG: Circulatory Tract- Collected Medicine Groups
- Academic research and communication skills (1, 2 and 3)

- Groningen Research Institute of Pharmacy (GRIP), Pharmaceutical Analysis Group: assistant professor (2022- )
- MD Anderson Cancer Center, Dept. of Symptom Research, Houston, TX, USA: postdoctoral researcher (2020-2022)
- Semmelweis University, Dept. of Pharmacology and Pharmacotherapy, Budapest, Hungary: assistant research fellow (2015-2019); assistant professor (2019)
- National Institute of Pharmacy and Nutrition, Budapest, Hungary: external clinical study evaluator (2018)

Research interests: pain; neuropathic pain; cancer pain; opioids; renin-angiotensin system; glycine transporters; neuro-immune interactions.

Medication safety, anticoagulation

* Ontwikkelen, implementeren en begeleiden van intervisie-bijeenkomsten voor studenten en professionals* Ontwikkelen, implementeren en uitvoeren van leerlijn professionele en academische vaardigheden voor Master studenten Farmacie
* Docent professionele ontwikkeling in Bachelor en Master geneeskunde

* Docent Apotheker Farmaceutische Patientenzorg

Multidrug-resistant tuberculosis; pediatrics

A/Prof. Job van Boven is a real-world drug outcomes expert specialised in lung diseases. He is the founding director of the Medication Adherence Expertise Center Of the northern Netherlands (MAECON) and Chair of the European Commission funded European Network to Advance Best Practices & Technology on Medication Adherence (ENABLE) COST Action, comprising 40 countries. He leads the research group on Cost-effective Drug Use (in Dutch: Doelmatig Geneesmiddelgebruik) at the Department of Clinical Pharmacy & Pharmacology of the University Medical Center Groningen and is Principal Investigator at the Groningen Research Institute for Asthma and COPD (GRIAC) and Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET) group of the UMCG.
He obtained his PharmD and PhD at the University of Groningen (The Netherlands), where his thesis focused on the cost-effectiveness of adherence enhancing interventions in patients with Chronic Obstructive Pulmonary Disease (COPD). After his PhD research, he completed fellowships at the University of Colorado (USA), Monash University (Australia) and the Hospital Universitario Son Espases (Spain).
He is (co)author of >150 scientific publications (H-index: 37), supervisor of 10 PhD students and received several research prices & grants (totalling>€6 million). He is Chair of the European Respiratory Society CRC on digital respiratory health "CONNECT", Chair of the Dutch respiratory pharmacists group (KNMP SIG Long), former Boardmember of the Dutch young Medicines Evaluation Board (Jong CBG), ZonMW-GGG committee member, Scientific lead of the Lung Alliance Netherlands (LAN) National Medication Adherence Program, expert research faculty at the IPCRG & EAACI, Editorial Board member of various peer-reviewed journals and has an extensive international network (e.g. ERS, IPCRG, EAACI, ISPE, REG, ESPACOMP, ISPOR).
Having interest and wide experience in both medication adherence and health economic methods, his mission is to find novel, cost-effective ways to make better, personalized use of our respiratory medications in order to maximize both patients’ and societal benefits.
Through multidisciplinary research, education and care support, he aims to provide means to accelerate implementation of drug-device technologies (digital inhalers, electronic pill bottles & blisters and smart spacers) and practical adherence monitoring & management tools (e.g. the TAI Toolkit) in daily clinical practice, to ultimately optimize patient, economic and societal outcomes.

Specialties:
- Methods & application: medication adherence, compliance, persistence, e-health, smart inhalers, bottles and spacers, digital adherence technology, (pharmaco) epidemiology, real-world drug outcomes, pharmacoeconomics, health economics, burden of disease, budget impact, health technology assessment, cost-effectiveness.
- Disease focus areas: Asthma / COPD / TB / CF/ Lung cancer  

Asthma, tuberculosis. (airway) remodelling, inflammation, extracellular matrix, integrins, signalling, therapeutic drug monitoring, toxicology

project management and other educational and research activities related to pharmacists education, pharmacoeconomics, regulatory affairs, health policy and practice

Drug formulations, Dosage forms for drugs; Biopharmaceutical aspects of drugs; Industrial production of drugs and dosage forms; Pulmonary drug administration; Stabilisation of biopharmaceuticals (proteins, vaccines, genetic material); Sugar glass technology; Tablets; Gastro-intestinal targeting of orally administered drugs; Coating, Formulation of poorly soluble drugs, Formulation and innovative routes of administration for vaccines

Dr. Ghimire works as a postdoctoral researcher at the department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen. Her research efforts focus on establishing or revising the doses of currently used anti-TB drugs by understanding the triangular relationship between drug doses, exposure and response in individual TB patients. In addition, she has a longstanding interest in evaluating and developing alternative samples for therapeutic drug monitoring such as saliva and dried-blood spots collected utilizing limited sampling time points.

Farmaceutical technology
Inhalation technology
Dry powder inhalation

Microfluidics, Organ-on-a-Chip

NWO-VENI laureate Prof. Hak and his multidisciplinary team have supervised >30 PhD theses on the validity of scientific statistical and epidemiological causal design methods to assess (side-) effects of drugs and vaccines using Real-World Big Health Care and Biobank Data. Scientific methods consider a variety of designs such as case-control, cohort, case-only, sibling designs, instrumental variable analysis, propensity score analysis often in combination with RCTs, meta-analyses and Individual Patient Data designs. His scientific work led to >400 peer-reviewed publications till 2021 (Web of Science H-index 44, >8,000 citations). As leader of the PharmLines Initiative,  a public-private collaboration between Lifelines BV-UMCG-RUG, he initiates and co-supervises research in the area of Precision Medicine with linked biobank, genetic, clinical, pharmacological and health care data of >80,000 persons from the Northern region. Topics mainly concern the pharmaco-epidemiology of preventive medications as well as vaccinations. In addition, his team supports the societal impact by studying the optimal methods to implement innovations in the area of sustainable drug applications and  vaccination strategies (e.g. drug repurposing, data science technologies to support optimal drug use, development of infection risk profiles and vaccination passport).

Prof. Hak is program director of the two-year Groningen Research Master Medical Pharmaceutical Sciences. As a director he implemented innovations regarding the extension of research tracks including Pharmaceutical Design & Engineering, Drug Toxicology &Translational Technologies and Pharmacoepidemiology & -Economics. With these tracks the complete drug development cycle can be studied within MPS. He further introduced a strong mentorate for students, monitoring of research projects, clear selection criteria for examiners and committee evaluations of research projects, which resulted in a Top-label in 2017 and 2019 by the influential Dutch Keuzegids (MPS belongs to the top-10% best master educations in the Netherlands). As educational director Pharmacy (>100 faculty) he applies his broad expertise to lead the cluster Pharmacy, also in close collaboration with sister Faculties.

Professor Clinical Pharmacy, in particular Oncology-Pharmacy

Analytical method development, Biomarkers, Drug metabolism, Exposomics, Liquid chromatography, Mass spectrometry, Metabolomics, Pharmacy, Proteomics, Regulated bioanalysis

Research on pharmaceutical education, in relation to workforce empowerment

Hospital and Clinical Pharmacy, clinical pharmacology

Areas of Interest and expertise include diabetes, nephrology, clinical pharmacology

Hospital Pharmacy, in particular personalised medicine in oncology
Radiopharmacy, molecular imaging

Nephrology and clinical chemistry

Health economic evaluation

PKPD Modeling and TDM

BiotechnologyPharmaceutical BiologyMolecular BiologyAntibiotics 
For more details See Publications in Google Scolar

Pharmacoepidemiology and safe use of psychotropic medications in pregnancy

FACULTY DEVELOPMENT for Health Professions Education

OTHER:
PhD research in teaching and learning patient-centered care;
communication skills for pharmacists, with special interest in interprofessional and multicultural communication; pharmaceutical care

Van der Schans has a background in medical pharmaceutical sciences with a focus on global health, epidemiology, (health) economics, and pharmacotherapy. He worked as a visiting researcher at the Department of Preventive and Social Medicine, University of Otago, and as a lecturer at the Department of Health Technology and Services Research, University of Twente.

Pharmacoepidemiology, Pharmacy Practice Research, Drug utilization, Pharmacotherapy

Pharmacokinetics

Safe and effective medication use focusing on vulnerable patient groups (older people with multimorbidity; people with diabetes/cardiovascular diseases) and infectious diseases; development and evaluation of (pharmacy-led) interventions to improve medication use; safety of hospital drug distribution systems; medication safety in low- and middle income countries.

Pharmacokinetics
Pharmacogenetics
Toxicology

Praktijkervaring vanuit de openbare apotheek op gebied van farmacotherapie, patientzorg, medicatiebeoordeling, management en organisatie, strategie, kwaliteitsbeheer, personeelsbeleid, interdisciplinaire samenwerking. Werkzaam geweest in verschillende apotheken waarbij 14 jaar als solist-eigenaar en 3 jaar als vennoot in een samenwerking met 6 apotheken. In 2015 en 2016 verkozen tot beste apotheek in Drenthe op basis van patientbeoordelingen. Daarnaast uitgebreide bestuurservaring in diverse gremia opgebouwd.

Teacher of the year Master Farmacie 2019, 2021

Product care, pharmaceutical compounding, pharmacy preparations, medicinal plants, phytotherapy, quality assurance in academic teaching

Clinical Pharmacology, Albuminuria, Renal function, Clinical Trials